Are you a new member? Sign up now
Login area
| Sign up
close
JAKAVI - 5mg - 56
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EJ01 | B | Ruxolitinib - 5mg | 11837 | 34623/1 | JAKAVI | 5mg | 56 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 159,222,240 L.L | 2.44 | E2 | Novartis Europharm Limited | Ireland | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EJ01 | G | Ruxolitinib - 5mg | 11479 | 152320/1 | CELEZON | 5mg | 56 | Tablet | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC | Jordan | 95,532,998 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| L01EJ01 | G | Ruxolitinib - 5mg | 11479/388 | 152320/1 | CELEZON | 5mg | 56 | Tablet | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC | Jordan | L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024